KPX Lifescience.Co.Ltd (114450) — Free Cash Flow Generation Index
KPX Lifescience.Co.Ltd (114450) has a Free Cash Flow Generation Index of 0.92x as of September 2025. Free cash flow of ₩3.05 Billion represents 1% of operating cash flow (₩3.33 Billion). See 114450 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
KPX Lifescience.Co.Ltd Free Cash Flow Generation Index (2014–2024)
Historical FCF Generation Index trend for KPX Lifescience.Co.Ltd across 10 annual periods. Explore KPX Lifescience.Co.Ltd (114450) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for KPX Lifescience.Co.Ltd (2014–2024)
Year-by-year Free Cash Flow Generation Index for KPX Lifescience.Co.Ltd. For the full company profile including market capitalisation, see KPX Lifescience.Co.Ltd market cap and net worth.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.12x | ₩62.78 Million | ₩525.49 Million | ₩462.71 Million | ▲ +142.1% |
| 2023 | -0.28x | ₩-105.00 Million | ₩370.02 Million | ₩475.02 Million | ▲ +93.9% |
| 2021 | -4.63x | ₩-2.83 Billion | ₩611.38 Million | ₩3.44 Billion | ▼ -1051.8% |
| 2020 | -0.40x | ₩-765.10 Million | ₩1.90 Billion | ₩2.67 Billion | ▼ -80.9% |
| 2019 | -0.22x | ₩-943.30 Million | ₩4.24 Billion | ₩3.60 Billion | ▼ -109.3% |
| 2018 | 2.39x | ₩12.87 Billion | ₩5.38 Billion | ₩7.49 Billion | ▲ +36.1% |
| 2017 | 1.76x | ₩9.99 Billion | ₩5.68 Billion | ₩4.31 Billion | ▲ +43.3% |
| 2016 | 1.23x | ₩8.67 Billion | ₩7.07 Billion | ₩1.60 Billion | ▲ +12.2% |
| 2015 | 1.09x | ₩6.14 Billion | ₩5.62 Billion | ₩526.82 Million | ▼ -9.3% |
| 2014 | 1.21x | ₩4.92 Billion | ₩4.09 Billion | ₩838.78 Million | — |